Moderna’s Bancel Dismisses GSK And Sanofi Challenge In mRNA Vaccines

New Entrants Will Find “It’s Much Harder Than They Think”

 
• By Andrew McConaghie
  
Stephane Bancel
Bancel doesn't rate GSK and Sanofi's chances in mRNA vaccines, warning they will face IP 'landmines'. • Source: Getty Images
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip